Explore the latest in prostate cancer, including recent screening guidelines and advances in management of localized and metastatic disease.
This dynamic cohort study evaluates the regional adoption of genomic testing for prostate cancer and the common trajectories of uptake shared by regions.
This study compares pathogenic variant detection accuracy in cancer-disposition genes of prostate cancer and melanoma cohort biopsy samples using deep learning vs standard genetic analysis methods.
This systematic review and meta-analysis examines 11 randomized clinical trials to see whether therapy with androgen receptor inhibitors (ARIs), such as enzalutamide, apalutamide, or darolutamide, is associated with an increased risk of falls and fractures in men with prostate cancer.
This diagnostic study evaluates whether the use of an artificial intelligence–based assistive tool is associated with improvements in the grading of prostate core needle biopsies among general pathologists compared with the majority opinion of subspecialists.
This case series study examines the prevalence of clonal hematopoiesis and its potential interference in prostate cancer cell-free DNA testing.
This cohort study estimates 10-year risk for disease progression, surgery, metastasis, and cause-specific and all-cause mortality among African American men with low-risk prostate cancer managed with active surveillance.
This narrative review discusses the use of postoperative radiotherapy in men with prostate cancer.
This cross-sectional survey study examines whether Black and White men with prostate cancer differ in their willingness to discuss clinical trials with their physicians, and if so, whether patient-level barriers are associated with racial differences.
This case series characterizes the antitumor activity of platinum-based therapies in men with castration-resistant prostate cancer with or without DNA repair gene alterations.
This cohort study develops and validates a pretreatment clinical prognostic stage group system for patients with nonmetastatic prostate cancer.
This case report describes a man in his 80s with red-to-brown scaly, flat-topped papules that coalesced into plaques with a cobblestone-like appearance on the head, trunk, and extremities, sparing the face, flexures, and skin folds.
This cohort study uses data from the Canary Prostate Active Surveillance Study and University of California, San Francisco to investigate whether monitoring frequency of men with diagnosed prostate cancer can be tailored based on risk stability outcomes.
This cohort study evaluates whether patients with higher-risk prostate cancer residing in Medicaid expansion states were more likely to receive treatment after expansion compared with patients in states that did not pursue Medicaid expansion.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: